Literature DB >> 30775559

The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases.

Seoung Hoon Lee1.   

Abstract

Entities:  

Year:  2018        PMID： 30775559      PMCID： PMC6372808          DOI： 10.1016/j.afos.2018.11.083

Source DB:  PubMed          Journal:  Osteoporos Sarcopenia        ISSN： 2405-5255


× No keyword cloud information.
  14 in total

Review 1.  Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.

Authors:  Princy Choudhary; Ayushi Gupta; Sangeeta Singh
Journal:  J Mol Neurosci       Date:  2020-10-13       Impact factor: 3.444

Review 2.  Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders.

Authors:  Sajeesh S; Shataakshi Dahal; Suraj Bastola; Simran Dayal; Jimmy Yau; Anand Ramamurthi
Journal:  Front Cardiovasc Med       Date:  2022-06-15

3.  Transplanted Erythropoietin-Expressing Mesenchymal Stem Cells Promote Pro-survival Gene Expression and Protect Photoreceptors From Sodium Iodate-Induced Cytotoxicity in a Retinal Degeneration Model.

Authors:  Avin Ee-Hwan Koh; Hiba Amer Alsaeedi; Munirah Binti Abd Rashid; Chenshen Lam; Mohd Hairul Nizam Harun; Min Hwei Ng; Hazlita Mohd Isa; Kong Yong Then; Mae-Lynn Catherine Bastion; Aisha Farhana; Mohammad Khursheed Alam; Suresh Kumar Subbiah; Pooi Ling Mok
Journal:  Front Cell Dev Biol       Date:  2021-04-27

4.  Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.

Authors:  Min-Jung Park; Jin-Ah Baek; Se-Young Kim; Kyung-Ah Jung; Jeong Won Choi; Sung-Hwan Park; Seung-Ki Kwok; Mi-La Cho
Journal:  J Transl Med       Date:  2020-12-14       Impact factor: 5.531

Review 5.  Conditioned medium derived from bovine umbilical mesenchymal stem cells as an alternative source of cell-free therapy.

Authors:  Dwi Liliek Kusindarta; Hevi Wihadmadyatami
Journal:  Vet World       Date:  2021-10-05

6.  Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy.

Authors:  Chi Zhang; Wei Zhang; Dashuai Zhu; Zhenhua Li; Zhenzhen Wang; Junlang Li; Xuan Mei; Wei Xu; Ke Cheng; Biao Zhong
Journal:  J Nanobiotechnology       Date:  2022-01-15       Impact factor: 10.435

Review 7.  Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine.

Authors:  Þóra Sigmarsdóttir; Sarah McGarrity; Óttar Rolfsson; James T Yurkovich; Ólafur E Sigurjónsson
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31

Review 8.  COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.

Authors:  Yogesh Kumar Verma; Ranjan Verma; Nishant Tyagi; Amanpreet Behl; Subodh Kumar; Gurudutta U Gangenahalli
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

Review 9.  Comparative characteristic study from bone marrow-derived mesenchymal stem cells.

Authors:  Medania Purwaningrum; Nabila Syarifah Jamilah; Steven Dwi Purbantoro; Chenphop Sawangmake; Sirirat Nantavisai
Journal:  J Vet Sci       Date:  2021-08-26       Impact factor: 1.672

10.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats.

Authors:  Seng Kar Yap; Kian Leong Tan; Nor Yasmin Abd Rahaman; Nur Fazila Saulol Hamid; Der Jiun Ooi; Yin Sim Tor; Qi Hao Daniel Looi; Li Kar Stella Tan; Chee Wun How; Jhi Biau Foo
Journal:  Pharmaceutics       Date:  2022-03-16       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.